Vitura Health Limited

VIT

AU0000266801

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 07:10:18 24/05/2024 BST			5-day change	1st Jan Change
0.093 ^AUD	0.00%		-15.45%	-63.53%

05-22	Vitura Health Resets Business Strategy	MT
04-26	Vitura Health's Shares Jump 19% After Securing Injunction Order Over Code4 Spat	MT

Cronos Australia Limited Provides Revenue Guidance for the Fourth Quarter of 2021

May 20, 2021 at 02:17 am

Cronos Australia Limited provided revenue guidance for the fourth quarter of 2021. For the quarter, the company expected sales to approach $600,000.

Latest news about Vitura Health Limited

Vitura Health Resets Business Strategy	05-22	MT
Vitura Health's Shares Jump 19% After Securing Injunction Order Over Code4 Spat	04-26	MT
Vitura Health's Services Agreement with Code4 at Risk of Termination; Shares Plunge 31%	04-23	MT
Vitura Health CEO to Step Down by June-End	04-22	MT
Vitura Health JV Commences Manufacture of GMP LaNeo MDMA; Shares Up 3%	04-05	MT
Vitura Health Joint Venture Supplies First Psilocybin for Patient Use Outside Trial	03-17	MT
Vitura Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-25	CI
Vitura Health Appoints Independent Chair	02-13	MT
Cronos Group Entering Australian Cannabis Market	01-09	MT
Vitura Health Integrates Nicotine Vaping Products into Prescription Platform	01-09	MT
Australian Shares Rally Following Christmas Holiday	12-27	MT
Vitura Health Services' Canview Services Deal to Not be Extended; Shares Plunge 20%	12-27	MT
Vitura Health's CanView Platform Achieves 2 Millionth Sale of Medicinal Cannabis	12-11	MT
Vitura Health Limited Responds to Elizabeth Sarah Jansen Comments	11-22	CI
Elizabeth Sarah Jansen Nominates Candidates to The Board of Vitura Health Limited	11-22	CI
Vitura Health Limited Receives Shareholder Requisition from Elizabeth Sarah Jansen	11-22	CI
Vitura Health Limited completed the acquisition of unknown minority stake in Doctors on Demand from Tacos Superannuation Fund, Martin Superannuation Fund, Sigma Company Limited, and Regal Emerging Companies Opportunities Fund and Regal Emerging Companies Fund III managed by Regal Partners Limited.	25/10/23	CI
Vitura Health Limited completed the acquisition of acquire an unknown stake in Doctors on Demand from Yeates Ventures Pty Ltd and Kirsty Garrett.	25/10/23	CI
Middle East Tensions, Rate Hike Concerns Drag Down Australian Shares	19/10/23	MT
Vitura Health Signs Agreement to Acquire Doctors on Demand; Shares Jump 6%	19/10/23	MT
Vitura Health Limited entered into share sale agreement to acquire an unknown stake in Doctors on Demand from Yeates Ventures Pty Ltd and Kirsty Garrett.	18/10/23	CI
Vitura Health Limited Board Changes	06/09/23	CI
Vitura Health Limited Announces Dividend for the Year Ended 30 June 2023, Payable on or Around, 28 September 2023	22/08/23	CI
Vitura Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023	22/08/23	CI
Vitura Health Secures WHO GDP Certification for Gold Coast and Melbourne Distribution Centers	26/07/23	MT

Vitura Health Limited is a diversified digital health company that operates various businesses via its subsidiaries CanView, Doctors on Demand, Cortexa, CDA Clinics, Cannadoc, BHC and Adaya. It consists of Medical segment involving the sale and distribution of medicinal cannabis products; Clinics segment involving the operation of medicinal cannabis clinics, and Consumer segment involving the sale of consumer (non-medical) products in both Australia and Asia. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy and supplier online platform, CanView, which sells and distributes 350+ therapeutic products and device stock-keeping units (SKUs) within Australia from medicinal cannabis producers. It also owns Doctors on Demand Pty Ltd, a telehealth platform business that provides primary health solutions. It owns 75.5% Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes telehealth consultations with patients seeking access to medicinal cannabis.

Sector

Pharmaceuticals

Calendar

27/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
VITURA HEALTH LIMITED	-63.53%	35.47M
DONG-E-E-JIAO CO.,LTD.	+39.27%	6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-18.60%	4.33B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.27%	3.22B
TASLY PHARMACEUTICAL GROUP CO., LTD	-15.69%	2.96B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-5.88%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+43.78%	1.92B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-11.89%	1.61B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.67%	1.57B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.39%	1.51B

Alternative Medicine

Vitura Health Limited

Equities

VIT

AU0000266801

Pharmaceuticals

Cronos Australia Limited Provides Revenue Guidance for the Fourth Quarter of 2021

Latest news about Vitura Health Limited

Chart Vitura Health Limited

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Alternative Medicine